骨桥蛋白
血管平滑肌
钙化
过氧化物酶体增殖物激活受体
碱性磷酸酶
免疫印迹
受体
油红O
内科学
内分泌学
医学
化学
生物化学
脂肪生成
基因
平滑肌
酶
脂肪组织
出处
期刊:Vascular
[SAGE]
日期:2021-10-20
卷期号:30 (6): 1224-1231
被引量:3
标识
DOI:10.1177/17085381211051477
摘要
The purpose of this study was to explore the role of ligustrazine in vascular calcification.After β-GP stimulation, vascular smooth muscle cells (VSMCs) were detected by Alizarin Red Staing staining. Calcium content and alkaline phosphatase (ALP) activity were detected by intracellular calcium assay kit and ALP assay kit, respectively. The expression of peroxisome proliferation-activated receptor (PPAR-γ) pathway-related proteins was detected by Western blot. PPAR-γ, MSX2, osteopontin (OPN), sclerostin, and BGP were detected by RT-PCR.β-GP induced the decreased activity and expression of PPAR-γ and ALP in VSMCs, while ligustrazine activated the expression of PPAR-γ. Through activation of PPAR-γ, ligustrazine decreased β-GP-induced VSMC calcification, decreased the expression of markers of osteogenesis and chondrogenic differentiation, and increased the expression of VSMC markers.Ligustrazine activates the PPAR-γ pathway and plays a protective role in vascular calcification.
科研通智能强力驱动
Strongly Powered by AbleSci AI